Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.
Previous research suggests identifying these warning signs can indicate a 95 per cent probability of death within 48 hours.